SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-17-002718
Filing Date
2017-02-16
Accepted
2017-02-16 17:58:46
Documents
2
Period of Report
2017-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 9726
2 ex24v2.htm EX-24 9373
  Complete submission text file 0001437749-17-002718.txt   20547
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Issuer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KEMPHARM, INC. 2500 CROSSPARK RD, STE E-126 CORALVILLE IA 52241
Business Address
Sangiovanni Timothy J. (Reporting) CIK: 0001698328 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36913 | Film No.: 17619105